# OnCo record eribulin (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/eribulin/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "eribulin" ;
  schema:name "Eribulin"@en ;
  schema:description "A sea-sponge-derived chemotherapy that extended survival in heavily pretreated breast cancer and in liposarcoma, where almost nothing else had."@en ;
  schema:url <https://onco.cc/drugs/eribulin/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Eribulin> ;
  owl:sameAs <http://www.wikidata.org/entity/Q408717> ;
  schema:citation <https://doi.org/10.1016/S0140-6736(11)60070-6>, <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=eribulin> ;
  onco:status "approved" ;
  onco:tag "gap-fill" ;
  onco:modality "Synthetic halichondrin B analogue (microtubule dynamics inhibitor)" ;
  schema:alternateName "Halaven" ;
  onco:approval "US 2010: Metastatic breast cancer after ≥2 regimens including an anthracycline and a taxane", "US 2016: Unresectable or metastatic liposarcoma after anthracycline", "EU 2011: Metastatic breast cancer; liposarcoma (2016)" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/sarcoma/>, <https://onco.cc/cancers/liposarcoma/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:companies <https://onco.cc/companies/eisai/> ;
  onco:terms <https://onco.cc/terms/payload/> ;
  onco:trials <https://onco.cc/trials/nct06435429/>, <https://onco.cc/trials/nct05824975/>, <https://onco.cc/trials/nct06081959/>, <https://onco.cc/trials/nct05458674/>, <https://onco.cc/trials/nct06202261/>, <https://onco.cc/trials/nct05814354/>, <https://onco.cc/trials/nct06942234/>, <https://onco.cc/trials/nct06343948/>, <https://onco.cc/trials/nct06449222/>, <https://onco.cc/trials/nct07173751/>, <https://onco.cc/trials/nct07007559/>, <https://onco.cc/trials/nct06957886/>, <https://onco.cc/trials/nct06279364/>, <https://onco.cc/trials/nct04639986/>, <https://onco.cc/trials/keynote-119/>, <https://onco.cc/trials/ascent/>, <https://onco.cc/trials/destiny-breast04/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-cortes-lancet/> .